Recent publications published by researchers at the MRC WIMM.
A review of broadly protective monoclonal antibodies to treat Ebola virus disease.
Rijal P. and Donnellan FR., (2023), Curr Opin Virol, 61
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern.
Ertesvåg NU. et al, (2022), Commun Med (Lond), 2
Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans.
Holzer B. et al, (2021), PLoS Pathog, 17
Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.
Huang K-YA. et al, (2021), PLoS Pathog, 17
Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation
Rahikainen R. et al, (2021), Angewandte Chemie, 133, 325 - 334
Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation.
Rahikainen R. et al, (2021), Angew Chem Int Ed Engl, 60, 321 - 330
Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell-cell fusion.
Thakur N. et al, (2021), J Gen Virol, 102
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient.
Zhou D. et al, (2020), Nat Struct Mol Biol, 27, 950 - 958
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.
Huo J. et al, (2020), Cell Host Microbe, 28, 445 - 454.e6
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
Huo J. et al, (2020), Nat Struct Mol Biol, 27, 846 - 854
Lung-targeting lentiviral vector for passive immunisation against influenza
TAN TK. et al, (2020), Thorax
Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans.
Rijal P. et al, (2020), J Virol, 94
Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by 1 trivalent influenza vaccine and H7N9 infection in humans
RIJAL P. and TOWNSEND A., (2019), Journal of Virology